Phase 2 bone marrow transplant drug trial on the horizon for Cynata Therapeutics
Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) may advance to a phase 2 clinical trial of a new stem cell drug if results of an initial two-stage trial continue to...
Kalium Lakes collars agreement with K+S for 100% of sulphate of potash offtake
Kalium Lakes (ASX: KLL) is closer to becoming what it claims is Australia’s first sulphate of potash producer after it announced it has attained an offtake agreement with one of the world’s largest sulphate...
Rhinomed partners with largest medical cannabis operator in the US
Australian medical technology company Rhinomed (ASX: RNO) has signed a deal that could see its nasal technology receive accelerated multilateral development and greater adoption in key markets around the world.
Rhinomed has signed a non-binding...
EVE Investments acquires leading Australian organic tea tree oil producer
EVE Investments (ASX: EVE) emerged out its trading halt earlier today to announce that it intends to acquire the entirety of organic tea tree oil producer Jenbrook for around A$2.9 million from its founder...
Rhythm Biosciences advances development of novel colorectal cancer test
Medical diagnostics technology company Rhythm Biosciences (ASX: RHY) is continuing the development of its novel test for colorectal cancer, named ColoSTAT.
As part of this work, the company says it has achieved a major technical...
Mt Remarkable offers up high-grade gold for King River Copper, while Speewah vanadium study continues
King River Copper (ASX: KRC) has struck up to 82.7 grams per tonne gold from ongoing drilling at its Mt Remarkable project, while reporting its vanadium concept study into unlocking the vanadium potential at...
Queensland Bauxite consolidates position in medical cannabis with double acquisition spree
After several months of tiptoeing in and around the medical cannabis market (and almost two months spent in a trading halt), Queensland Bauxite (ASX: QBL) has plunged in two feet first by carrying out...
Legend Mining uncovers third mineralised body at Rockford nickel-copper project
Aircore drilling at Legend Mining’s (ASX: LEG) Rockford project in Western Australia has returned nickel-copper sulphide mineralisation, confirming a third mineralised intrusive body.
The company requested a trading halt this morning before announcing the assay...
Botanix Pharmaceuticals fully funded to complete phase 2 atopic dermatitis trial
Medical dermatology company Botanix Pharmaceuticals (ASX: BOT) has raised A$8 million through an oversubscribed placement to professional, institutional and sophisticated investors across Australia and Asia.
The raising comes at a critical juncture in the company’s development as...
Bass Metals earmarks lithium targets at Millie’s Reward
Bass Metals (ASX: BSM) continues to report steady progress during its phase 1 field assessment program across eight exploration targets within the highly-prospective Millie’s Reward lithium project in central Madagascar.
Four of those exploration targets...
